 |
59 Diseases |  |
24 Trials |
|
24 Trials |  |
1996 News |  |
| «12...14151617181920212223242526 |
- lacosamide / Generic mfg.
Trial completion: IV Lacosamide: The Safety of Intravenous Lacosamide (clinicaltrials.gov) - Nov 7, 2013
P3, N=40, Completed, Sponsor: Le Bonheur Children's Hospital
Not yet recruiting --> Completed
- lacosamide / Generic mfg.
Trial completion: The Safety of Intravenous Lacosamide (clinicaltrials.gov) - Nov 4, 2013
P4, N=40, Completed, Sponsor: Le Bonheur Children's Hospital
Not yet recruiting --> Completed Recruiting --> Completed
- | lacosamide / Generic mfg.
New P2 trial: A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures. (clinicaltrials.gov) - Oct 23, 2013
P2, N=50, Recruiting, Sponsor: UCB, Inc.
- | lacosamide / Generic mfg.
Enrollment open: A Study to Investigate the Safety and Efficacy of Lacosamide Added to the Patients Current Therapy in Patients Aged 1 Month to Less Than 18 Years Old With Epilepsy Syndromes Associated With Generalized Seizures. (clinicaltrials.gov) - Oct 20, 2013
P2, N=50, Recruiting, Sponsor: UCB, Inc.
Recruiting --> Completed Not yet recruiting --> Recruiting
- |||||||||| lacosamide / Generic mfg.
New P3 trial: A Clinical Study to Investigate the Efficacy and Safety of Lacosamide as an Add on Therapy in Children With Epilepsy With Partial-onset Seizures (clinicaltrials.gov) - Oct 15, 2013
P3, N=500, Enrolling by invitation, Sponsor: UCB, Inc.
- ||| lacosamide / Generic mfg.
Enrollment change: Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures (clinicaltrials.gov) - Aug 28, 2013
P4, N=461, Completed, Sponsor: UCB, Inc.
Not yet recruiting --> Recruiting N=656 --> 461
- |||| lacosamide / Generic mfg.
Trial completion: Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset Seizures (clinicaltrials.gov) - Aug 28, 2013
P4, N=461, Completed, Sponsor: UCB, Inc.
N=656 --> 461 Active, not recruiting --> Completed
- ||| lacosamide / Generic mfg.
Enrollment change: An Open-Label Study to Determine Safety , Tolerability, and Efficacy of Oral Lacosamide in Children With Epilepsy (clinicaltrials.gov) - Aug 23, 2013
P2, N=192, Enrolling by invitation, Sponsor: UCB, Inc.
Active, not recruiting --> Completed N=42 --> 192
- |||||||||| lacosamide / Generic mfg.
New P3 trial: Study to Investigate Lacosamide as Add-on Therapy in Subjects ?4 Years to <17 Years of Age With Partial Onset Seizures (clinicaltrials.gov) - Aug 11, 2013
P3, N=300, Ongoing, Sponsor: UCB BIOSCIENCES, Inc.
- lacosamide / Generic mfg.
New P3 trial: Safety and Tolerability of Lacosamide in Patients With Gain-of-function Nav1.7 Mutations Related Small Fiber Neuropathy (clinicaltrials.gov) - Jul 28, 2013
P3, N=25, Not yet recruiting, Sponsor: Academisch Ziekenhuis Maastricht
- ||| lacosamide / Generic mfg.
Trial completion: VITOBA: Vimpat (clinicaltrials.gov) - Jul 14, 2013
P=N/A, N=576, Completed, Sponsor: UCB Pharma GmbH
N=42 --> 192 Active, not recruiting --> Completed
- ||| lacosamide / Generic mfg.
Trial initiation date: Lacosamide IV and EEG/EKG (LIVE) Study (clinicaltrials.gov) - Jul 11, 2013
P2, N=90, Recruiting, Sponsor: Lawson Health Research Institute
Active, not recruiting --> Completed Initiation date: Nov 2012 --> May 2013
- |||| lacosamide / Generic mfg.
Enrollment open: Lacosamide IV and EEG/EKG (LIVE) Study (clinicaltrials.gov) - Jul 11, 2013
P2, N=90, Recruiting, Sponsor: Lawson Health Research Institute
Initiation date: Nov 2012 --> May 2013 Not yet recruiting --> Recruiting
- lacosamide / Generic mfg.
New P3 trial: IV Lacosamide: The Safety of Intravenous Lacosamide (clinicaltrials.gov) - May 12, 2013
P3, N=40, Completed, Sponsor: Le Bonheur Children's Hospital
- |||||||||| lacosamide / Generic mfg.
New P3 trial: Study to Evaluate the Safety, Tolerability, and Efficacy of Long-term Adjunctive Therapy With Lacosamide in Adults With Partial-onset Seizures (clinicaltrials.gov) - Apr 11, 2013
P3, N=378, Recruiting, Sponsor: UCB Pharma SA
- || lacosamide / Generic mfg.
Trial initiation date: Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects (clinicaltrials.gov) - Feb 27, 2013
P1, N=60, Completed, Sponsor: UCB, Inc.
Not yet recruiting --> Recruiting Initiation date: Feb 2012 --> May 2012
- | lacosamide / Generic mfg.
New P1 trial: Study to Evaluate the Pharmacokinetics, Safety, Tolerability of Single Dose Lacosamide in Subjects With Renal Impairment Compared to Healthy Subjects (clinicaltrials.gov) - Feb 20, 2013
P1, N=40, Completed, Sponsor: UCB BIOSCIENCES GmbH
- ||||||| lacosamide / Generic mfg.
Trial completion, Monotherapy: ALEX-MT: Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures (clinicaltrials.gov) - Dec 10, 2012
P3, N=427, Completed, Sponsor: UCB, Inc.
Initiation date: Feb 2012 --> May 2012 Active, not recruiting --> Completed
- lacosamide / Generic mfg.
Biomarker, Enrollment open: A Pharmacogenomic Exploration of Lacosamide Response (clinicaltrials.gov) - Dec 4, 2012
P=N/A, N=660, Recruiting, Sponsor: Royal College of Surgeons, Ireland
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| lacosamide / Generic mfg.
New P2 trial: Lacosamide IV and EEG/EKG (LIVE) Study (clinicaltrials.gov) - Nov 8, 2012
P2, N=90, Recruiting, Sponsor: Lawson Health Research Institute
- | lacosamide / Generic mfg.
Trial completion: Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy (clinicaltrials.gov) - Oct 25, 2012
P2, N=39, Completed, Sponsor: UCB, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- |||||||||| lacosamide / Generic mfg.
New P3 trial: A Trial to Evaluate the Efficacy and Safety of Adjunctive Therapy With Lacosamide in Adults With Partial-Onset Seizures (clinicaltrials.gov) - Oct 17, 2012
P3, N=540, Active, not recruiting, Sponsor: UCB Pharma SA
- |||| lacosamide / Generic mfg., fosphenytoin / Generic mfg.
Enrollment open: Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures (clinicaltrials.gov) - Sep 13, 2012
P2, N=200, Recruiting, Sponsor: Aatif Husain
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | lacosamide / Generic mfg.
Trial completion: Effects of Lacosamide on Human Motor Cortex Excitability: a Transcranial Magnetic Stimulation Study (clinicaltrials.gov) - Aug 27, 2012
P=N/A, N=18, Completed, Sponsor: University of Kiel
Not yet recruiting --> Recruiting Recruiting --> Completed
- | lacosamide / Generic mfg.
Trial completion: A Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy Subjects (clinicaltrials.gov) - Aug 15, 2012
P1, N=25, Completed, Sponsor: UCB, Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- lacosamide / Generic mfg.
Enrollment open: Lacosamide in Preventing Seizures in Participants With Malignant Glioma (clinicaltrials.gov) - Jul 24, 2012
P=N/A, N=302, Recruiting, Sponsor: M.D. Anderson Cancer Center
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||| lacosamide / Generic mfg.
Enrollment open, HEOR: Effects of Adjunctive Lacosamide on Mood States and Quality of Life (QOL) in Patients With Epilepsy (clinicaltrials.gov) - Jun 5, 2012
P=N/A, N=60, Recruiting, Sponsor: State University of New York - Downstate Medical Center
Not yet recruiting --> Recruiting Not yet recruiting --> Recruiting
- | lacosamide / Generic mfg.
Trial completion: Effect of Lacosamide 200 mg Twice a Day (Bid) on Single Dose Warfarin 25 mg in Healthy Males (clinicaltrials.gov) - May 3, 2012
P1, N=16, Completed, Sponsor: UCB, Inc.
Not yet recruiting --> Recruiting Recruiting --> Completed
- ||| Potiga (retigabine) / Bausch Health, GSK
Review: Systematic Review: Retigabine for Adjunctive Therapy in Partial Epilepsy (clinicaltrials.gov) - Apr 25, 2012
P=N/A, N=6498, Completed, Sponsor: GlaxoSmithKline
- ||| lacosamide / Generic mfg.
Trial completion: Belgian Drug-utilization Study to Evaluate the Use of VIMPAT (clinicaltrials.gov) - Apr 22, 2012
P=N/A, N=192, Completed, Sponsor: UCB, Inc.
Recruiting --> Completed Active, not recruiting --> Completed
- ||| lacosamide / Generic mfg.
Trial completion: PASS: Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset Seizures (clinicaltrials.gov) - Apr 18, 2012
P=N/A, N=1005, Completed, Sponsor: UCB, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||| lacosamide / Generic mfg., fosphenytoin / Generic mfg.
Trial initiation date: Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures (clinicaltrials.gov) - Mar 14, 2012
P2, N=200, Recruiting, Sponsor: Aatif Husain
Active, not recruiting --> Completed Initiation date: Feb 2012 --> May 2012
- | lacosamide / Generic mfg.
New P1 trial: A Multicenter, Open-label Study to Determine the Effects of Lacosamide on Sleep in Healthy Subjects (clinicaltrials.gov) - Feb 7, 2012
P1, N=25, Completed, Sponsor: UCB, Inc.
- ||| lacosamide / Generic mfg.
New P1 trial: Crossover Study of Neuropsychological Effects of Lacosamide and Carbamazepine Immediate Release in Healthy Subjects (clinicaltrials.gov) - Feb 7, 2012
P1, N=60, Completed, Sponsor: UCB, Inc.
- | lacosamide / Generic mfg.
New P1 trial: Effect of Lacosamide 200 mg Twice a Day (Bid) on Single Dose Warfarin 25 mg in Healthy Males (clinicaltrials.gov) - Feb 1, 2012
P1, N=16, Completed, Sponsor: UCB, Inc.
- lacosamide / Generic mfg.
Trial termination: A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide (clinicaltrials.gov) - Jan 22, 2012
P=N/A, N=11, Terminated, Sponsor: University of Alabama at Birmingham
Initiation date: Feb 2012 --> May 2012 Recruiting --> Terminated; Lack of enrollement
- lacosamide / Generic mfg.
Enrollment change: A Pilot Study of NSICU Assessment of Seizure Prophylaxis With Lacosamide (clinicaltrials.gov) - Jan 22, 2012
P=N/A, N=11, Terminated, Sponsor: University of Alabama at Birmingham
Recruiting --> Terminated; Lack of enrollement N=52 --> 11
- ||| lacosamide / Generic mfg.
Enrollment change: SELF: Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure (clinicaltrials.gov) - Jan 3, 2012
P4, N=100, Completed, Sponsor: UCB, Inc.
N=52 --> 11 N=200 --> 100
- |||| lacosamide / Generic mfg.
Trial completion: SELF: Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset Seizure (clinicaltrials.gov) - Jan 3, 2012
P4, N=100, Completed, Sponsor: UCB, Inc.
N=200 --> 100 Active, not recruiting --> Completed
- |||||||||| lacosamide / Generic mfg.
New P3 trial: VERVE: eValuation of the Efficacy and toleRability of Vimpat When Added to lEvetiracetam (clinicaltrials.gov) - Dec 1, 2011
P3, N=120, Completed, Sponsor: UCB, Inc.
- |||||||||| lacosamide / Generic mfg., carbamazepine / Generic mfg.
New P3 trial, Monotherapy: Evaluating Long Term Safety of Lacosamide (LCM) to Carbamazepine Controlled-release (CBZ-CR); Initial Monotherapy in Epilepsy Subjects 16 Years and Older (clinicaltrials.gov) - Nov 3, 2011
P3, N=527, Recruiting, Sponsor: UCB BIOSCIENCES GmbH
- ||||| lacosamide / Generic mfg., fosphenytoin / Generic mfg.
New P2 trial: Intravenous Lacosamide Compared With Fosphenytoin in the Treatment of Patients With Frequent Nonconvulsive Seizures (clinicaltrials.gov) - Oct 23, 2011
P2, N=200, Recruiting, Sponsor: Aatif Husain
- ||| lacosamide / Generic mfg.
New P1 trial: To Evaluate the Pharmacokinetics and Safety/Tolerability of Lacosamide in 3 Dosages in Healthy Male Korean Subjects (clinicaltrials.gov) - Oct 6, 2011
P1, N=51, Completed, Sponsor: UCB, Inc.
- | lacosamide / Generic mfg.
Trial completion: Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy (clinicaltrials.gov) - Sep 7, 2011
P2, N=49, Completed, Sponsor: UCB, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | lacosamide / Generic mfg.
Trial completion: Three-way-cross-over Study to Evaluate Safety and Pharmacokinetics of Lacosamide in Healthy Japanese and Chinese Males (clinicaltrials.gov) - Aug 21, 2011
P1, N=33, Completed, Sponsor: UCB, Inc.
Active, not recruiting --> Completed Active, not recruiting --> Completed